SeaPET 2019-2022

SeaPET: Development of seaweed-based bioactive ingredients for pet supplement
Partnership: ISS, CIIMAR, IPMA, Zu, Barkyn, WePharm, 11Pets

• Responsible:
  
• Funding Entity:
• Reference:
• Funding Total:
• Duration:
  

Objective:
Development of bioactive compounds derived from seaweed with bioactivity characteristic for natural pet supplement production.